Literature DB >> 19303571

Alternative strategies for Clostridium difficile infection.

Martijn P Bauer1, Jaap T van Dissel.   

Abstract

Although antibiotics are generally effective in achieving symptomatic recovery from Clostridium difficile infection, the disease frequently relapses, partly because antibiotics not only kill C. difficile, but also disrupt colonisation resistance of the gut microflora. Non-antibiotic strategies for the prevention and treatment of the infection include probiotics, deliberate colonisation by non-toxigenic C. difficile strains, toxin-binding agents, active immunisation, passive immunotherapy with intravenous immunoglobulin, monoclonal antibodies or bovine anti-C. difficile whey concentrate, and faecal transplantation. None of these alternative therapies has proven benefit in therapy or prevention, and prospective randomised trials are urgently needed.

Entities:  

Mesh:

Year:  2009        PMID: 19303571     DOI: 10.1016/S0924-8579(09)70018-4

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

Review 1.  [New antibiotics: small or big advances?].

Authors:  R Draenert; J R Bogner
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

2.  Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.

Authors:  Joseph M Sturino; Karina Pokusaeva; Robert Carpenter
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

3.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.

Authors:  Melinda A Engevik; Kristen A Engevik; Mary Beth Yacyshyn; Jiang Wang; Daniel J Hassett; Benjamin Darien; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

4.  Human Clostridium difficile infection: altered mucus production and composition.

Authors:  Melinda A Engevik; Mary Beth Yacyshyn; Kristen A Engevik; Jiang Wang; Benjamin Darien; Daniel J Hassett; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

5.  A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection.

Authors:  Theodore Rokkas; Javier P Gisbert; Antonio Gasbarrini; Georgina L Hold; Herbert Tilg; Peter Malfertheiner; Francis Megraud; Colm O'Morain
Journal:  United European Gastroenterol J       Date:  2019-05-27       Impact factor: 4.623

6.  Prevalence and management of antibiotic associated diarrhea in general hospitals.

Authors:  Monique M Elseviers; Yoleen Van Camp; Sander Nayaert; Khyra Duré; Lieven Annemans; Ann Tanghe; Sebastian Vermeersch
Journal:  BMC Infect Dis       Date:  2015-03-17       Impact factor: 3.090

7.  Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.

Authors:  Janet Y Nale; Tamsin A Redgwell; Andrew Millard; Martha R J Clokie
Journal:  Antibiotics (Basel)       Date:  2018-02-13

Review 8.  Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.

Authors:  Beatrix Förster; Pui Khi Chung; Monique J T Crobach; Ed J Kuijper
Journal:  Front Microbiol       Date:  2018-06-25       Impact factor: 5.640

9.  Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Authors:  Zeid Karadsheh; Sachin Sule
Journal:  N Am J Med Sci       Date:  2013-06

Review 10.  Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.

Authors:  Reena Pattani; Valerie A Palda; Stephen W Hwang; Prakeshkumar S Shah
Journal:  Open Med       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.